Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source
Rethinking the Origins of Cross-Language Effects: How Heard Verbs Influence Japanese- and English-Speaking Children's Attention to the Details of Actions. [PDF]
Hagihara H +3 more
europepmc +1 more source
A Novel Cell-Penetrating Lipopeptide for DNA Binding, Self-Assembly, and Delivery Into HeLa and Pluripotent Stem Cells. [PDF]
de Mello LR +6 more
europepmc +1 more source
The Sense of Security and Associated Factors Among Older Home Care Clients: A Register Study. [PDF]
Mira P +4 more
europepmc +1 more source
Morphological Changes and MRI Characteristics of the Achilles Tendon in Amateur Marathon Runners With Different Running Experience. [PDF]
Yao W +8 more
europepmc +1 more source
Validation of the Multiracial Youth Socialization Brief (MY-Soc-B) Scale with adolescents. [PDF]
Atkin AL +4 more
europepmc +1 more source
Correction to "Evaluation of ImpENSA Technology-Enabled Behaviour Change Module Delivered to Healthcare Professionals in South Africa to Improve Micronutrient Nutrition During the First 1000 Days". [PDF]
europepmc +1 more source
Related searches:
Naloxone hydrochloride, a synthetic N-allyl derivative of oxymorphone, is an effective agent for the reversal of the cardiovascular and respiratory depression associated with narcotic and possibly some non-narcotic overdoses. It is essentially a pure narcotic antagonist, is relatively safe, and is a useful diagnostic and therapeutic agent.
K A, Handal +2 more
openaire +3 more sources
Perinatal naloxone: When does naloxone affect hyperalgesia?
Pharmacology Biochemistry and Behavior, 1979Pregnant mice were treated with naloxone via subcutaneous implants, from about 5 days prior to parturition. At birth entire litters were cross-fostered so that groups of offspring were exposed to naloxone treated mothers; before birth, after birth to weaning, from about 5 days prior to birth to weaning, or not exposed to naloxone.
H, Monder, N, Yasukawa, J J, Christian
openaire +2 more sources

